Literature DB >> 17280586

Mechanisms of hypersensitivity in IBS and functional disorders.

F Azpiroz1, M Bouin, M Camilleri, E A Mayer, P Poitras, J Serra, R C Spiller.   

Abstract

General introduction The concept of visceral hypersensitivity is accepted as being germane to several functional gastrointestinal disorders (FGIDs). The causes or risk factors associated with this hypersensitivity are unclear. This article addresses the proposed mechanisms leading to hypersensitivity: from genetic to inflammatory disorders, from central to peripheral alterations of function. However, in order to place visceral hypersensitivity in a more global perspective as an aetiological factor for FGIDs, it also provides a review of recent evidence regarding the role of other peripheral mechanisms (the intraluminal milieu), as also genetic factors in the pathophysiology of these disorders. The article has been divided into five independent sections. The first three sections summarize the evidence of visceral hypersensitivity as a biological marker of functional gut disorders, the peripheral and central mechanisms involved, and the role of inflammation on hypersensitivity. In opposition to visceral hypersensitivity as an isolated phenomenon in functional gut disorders, the last two sections focus on the importance of peripheral mechanisms, like motor disturbances, specifically those resulting on altered transport of intestinal gas, and alterations of the intraluminal milieu and genetics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280586     DOI: 10.1111/j.1365-2982.2006.00875.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  115 in total

1.  Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities.

Authors:  Antonio M Scanu; Tim J Bull; Sara Cannas; Jeremy D Sanderson; Leonardo A Sechi; Giuseppe Dettori; Stefania Zanetti; John Hermon-Taylor
Journal:  J Clin Microbiol       Date:  2007-10-03       Impact factor: 5.948

Review 2.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

Review 3.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

4.  Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.

Authors:  Uri Ladabaum; Annie Sharabidze; Theodore R Levin; Wei K Zhao; Elaine Chung; Peter Bacchetti; Chengshi Jin; Barbara Grimes; Craig J Pepin
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-16       Impact factor: 11.382

5.  Mechanisms of Probiotic VSL#3 in a Rat Model of Visceral Hypersensitivity Involves the Mast Cell-PAR2-TRPV1 Pathway.

Authors:  Ying-Jie Li; Cong Dai; Min Jiang
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

6.  Sex-related differences in prepulse inhibition of startle in irritable bowel syndrome (IBS).

Authors:  L A Kilpatrick; E Ornitz; H Ibrahimovic; M Treanor; M Craske; M Nazarian; J S Labus; E A Mayer; B D Naliboff
Journal:  Biol Psychol       Date:  2010-03-01       Impact factor: 3.251

Review 7.  Abdominal bloating and distension: what is the role of the microbiota.

Authors:  B Issa; N A Wafaei; P J Whorwell
Journal:  Dig Dis Sci       Date:  2011-07-29       Impact factor: 3.199

8.  Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.

Authors:  Hilary Schenck Eidam; John Russell; Kaushik Raha; Michael DeMartino; Donghui Qin; Huiping Amy Guan; Zhiliu Zhang; Gong Zhen; Haiyu Yu; Chengde Wu; Yan Pan; Gerard Joberty; Nico Zinn; Sylvie Laquerre; Sharon Robinson; Angela White; Amanda Giddings; Ehsan Mohammadi; Beverly Greenwood-Van Meerveld; Allen Oliff; Sanjay Kumar; Mui Cheung
Journal:  ACS Med Chem Lett       Date:  2018-05-24       Impact factor: 4.345

9.  Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

Authors:  Ji-Meng Zhao; Jin-Hua Lu; Xiao-Jun Yin; Lu-Yi Wu; Chun-Hui Bao; Xing-Kui Chen; Yue-Hua Chen; Wei-Jun Tang; Xiao-Ming Jin; Huan-Gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

10.  The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study.

Authors:  Chen-Yi Wu; Wei-Pin Chang; Yen-Hou Chang; Chung-Pin Li; Chi-Mu Chuang
Journal:  Int J Colorectal Dis       Date:  2015-04-28       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.